Korean J Med.  2014 Jul;87(1):34-38.

Diagnosis and Treatment of Polymyalgia Rheumatica

Affiliations
  • 1Division of Rheumatology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. bestmd2000@amc.seoul.kr

Abstract

Polymyalgia rheumatica (PMR) is a chronic inflammatory disorder that usually affects adults over 50 years of age. It is characterized by pain and stiffness of the neck, shoulders and hips. Laboratory tests have shown marked elevation of acute phase reactants (ESR and CRP), but there is no specific test to diagnose PMR. Recently, the European League Against Rheumatism and the American College of Rheumatology jointly proposed a new set of classification criteria for PMR. The mainstay of PMR treatment is low-dose glucocorticoids (prednisolone 10-20 mg/day). patients with PMR usually respond very well to steroid therapy within a few days to one week, but will often relapse despite treatment.

Keyword

Polymyalgia rheumatica; Criteria; Treatment

MeSH Terms

Acute-Phase Proteins
Adult
Classification
Diagnosis*
Glucocorticoids
Hip
Humans
Neck
Polymyalgia Rheumatica*
Recurrence
Rheumatic Diseases
Rheumatology
Shoulder
Acute-Phase Proteins
Glucocorticoids
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr